ALTO NEUROSCIENCE, INC.

ALTO NEUROSCIENCE, INC. is a biotech company in Los Altos, United States, founded in 2020. It has raised $168.2M across 3 rounds, most recently a $120.0M Growth Equity in March 2026.

Leading Innovation in Psychiatric Treatment | Alto Neuroscience

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$168.2M
Last Round
$120.0M Growth EquityMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Alto Neuroscience is a clinical-stage biopharmaceutical company redefining psychiatry by leveraging deep neurobiological insights to develop personalized medicines for neuropsychiatric conditions. Using a precision psychiatry platform built on 15 years of neurobiology research, the company targets core brain processes in patients with major depressive disorder, bipolar depression, and schizophrenia.

Summary

It lists 1–10 employees. It has raised $168.2M in total across 3 rounds, most recently a $120.0M Growth Equity round in Mar 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityMar 2026
$120.0M

Sign up to see all 3 events

Funding: Grant through Growth Equity. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ALTO NEUROSCIENCE, INC. on Indexed.vc
<a href="https://indexed.vc/companies/alto-neuroscience-inc"><img src="https://indexed.vc/api/badge/company/alto-neuroscience-inc" alt="ALTO NEUROSCIENCE, INC. on Indexed.vc" width="260" height="76" /></a>